KFSH cuts heart failure admissions 46.4% with remote monitoring

King Faisal Specialist Hospital and Research Centre says implantable pulmonary artery pressure monitoring cut decompensated heart failure admissions by 46.4% in a review of 130 patients in Riyadh. The finding points to a wider shift toward at-home specialist oversight that can reduce emergency visits and preserve hospital capacity.

Why it matters: - Remote monitoring can keep heart failure patients out of the hospital longer and let specialists intervene earlier. - The approach reduces disruptions for patients and families. - It also preserves inpatient capacity for people who need acute care.

What happened: - King Faisal Specialist Hospital and Research Centre said a center analysis found a 46.4% reduction in hospital admissions for decompensated heart failure among patients fitted with an implantable pulmonary artery pressure sensor. - The analysis covered 130 recipients who completed six months of follow-up. - The comparison used each patient’s experience before implantation. - The sensor used was CardioMEMS.

The details: - The CardioMEMS sensor lets KFSH’s Heart Center of Excellence monitor pulmonary artery pressure remotely. - Clinical teams can identify early signs of worsening heart failure. - Teams can adjust treatment while the patient remains at home. - KFSH said remote monitoring is part of a broader set of technologies that extend specialist oversight beyond the hospital. - The center also uses artificial intelligence to support electrocardiogram analysis. - KFSH offers leadless pacemakers for selected pediatric and congenital heart disease patients. - A round-the-clock virtual cardiac service handles urgent concerns after discharge through defined escalation pathways. - KFSH provides advanced heart failure care, including ventricular assist devices, extracorporeal membrane oxygenation, and heart transplantation. - The center records more than 70,000 outpatient visits each year. - KFSH performed the world’s first fully robotic heart transplant in 2024. - KFSH performed the world’s first robotic-assisted implantation of a HeartMate 3 heart pump in 2025.

Between the lines: - The results reflect a care model built around continuous management of chronic heart failure rather than episodic treatment. - The technology lets specialist teams stay connected to patients between visits, which can shift care away from emergency settings. - KFSH is also using high-profile surgical milestones and digital tools to reinforce its position as a regional and global specialty center.

What's next: - KFSH is likely to keep expanding remote monitoring and virtual cardiac follow-up as part of its heart failure program. - The hospital may continue using the approach to support patients who need closer long-term surveillance while limiting avoidable admissions. - KFSH said the model fits its broader specialist care pathway for patients whose disease progresses.

The bottom line: - KFSH is showing that remote cardiac monitoring can materially reduce hospital use while keeping high-risk heart failure patients under closer specialist supervision.